Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Dynavax Technologies revenue
Dynavax Technologies's revenue is $277.2 million.
What is Dynavax Technologies's revenue?
- Dynavax Technologies's revenue growth from 2002 to 2024 is 19,328.59%.
- Dynavax Technologies has 311 employees, and the revenue per employee ratio is $891,466.
- Dynavax Technologies's peak quarterly revenue was $256.5M in 2022(q2).
- Dynavax Technologies peak revenue was $722.7M in 2022.
- Dynavax Technologies annual revenue for 2023 was 232.3M, -67.86% growth from 2022.
- Dynavax Technologies annual revenue for 2024 was 277.2M, 19.36% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Dynavax Technologies historical revenue
Dynavax Technologies's peak revenue was $722.7M in 2022. The peak quarterly revenue was $256.5M in 2022(q2).
Dynavax Technologies's revenue increased from $1.4m in 2002 to $277.2M currently. That's a 19,328.59% change in annual revenue.
Dynavax Technologies annual revenue
Dynavax Technologies annual revenue over time
| Fiscal year / year | Dynavax Technologies revenue |
|---|---|
| 2009 | $40.3M |
| 2010 | $24.0M |
| 2011 | $21.6M |
| 2012 | $9.7M |
| 2013 | $11.3M |
| 2014 | $11.0M |
| 2015 | $4.1M |
| 2016 | $11.0M |
| 2017 | $327,000 |
| 2018 | $8.2M |
| 2019 | $35.2M |
| 2020 | $46.6M |
| 2021 | $439.4M |
| 2022 | $722.7M |
| 2023 | $232.3M |
| 2024 | $277.2M |
Rate Dynavax Technologies' financial transparency
Dynavax Technologies annual growth
Dynavax Technologies saw the greatest revenue growth in 2018, when revenue increased by 2,407.03%.
Dynavax Technologies had the lowest revenue growth in 2017, when revenue changed by -97.04%.
Dynavax Technologies annual growth rate over time
| Year | Dynavax Technologies growth |
|---|---|
| 2009 | 9%↑ |
| 2010 | -41%↓ |
| 2011 | -10%↓ |
| 2012 | -55%↓ |
| 2013 | 16%↑ |
| 2014 | -2%↓ |
| 2015 | -63%↓ |
| 2016 | 173%↑ |
| 2017 | -97%↓ |
| 2018 | 2407%↑ |
| 2019 | 330%↑ |
| 2020 | 32%↑ |
| 2021 | 844%↑ |
| 2022 | 64%↑ |
| 2023 | -68%↓ |
| 2024 | 19%↑ |
Dynavax Technologies quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Dynavax Technologies quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $19.3M | $15.9M | $2.9M | $2.2M |
| 2010 | $8.3M | $2.2M | $11.6M | $1.8M |
| 2011 | $1.7M | $7.3M | $1.2M | $11.4M |
| 2012 | $2.4M | $2.7M | $2.9M | ($2.1M) |
| 2013 | $2.1M | $3.4M | $2.9M | ($2.3M) |
| 2014 | $3.5M | $3.0M | $2.2M | $2.3M |
| 2015 | $627,000 | $1.6M | $1.2M | $685,000 |
| 2016 | $942,000 | $2.6M | $162,000 | $7.3M |
| 2017 | $148,000 | $105,000 | $53,000 | $21,000 |
| 2018 | $165,000 | $1.3M | $1.5M | $5.3M |
| 2019 | $5.8M | $8.3M | $10.6M | $10.6M |
| 2020 | $10.9M | $2.7M | $13.4M | $19.6M |
| 2021 | $83.3M | $52.8M | $108.3M | $195.1M |
| 2022 | $114.0M | $256.5M | $167.7M | $184.5M |
| 2023 | $46.9M | $60.2M | $69.5M | $55.6M |
| 2024 | $50.8M | $73.8M | $80.6M | $72.0M |
Dynavax Technologies jobs nearby
Do you work at Dynavax Technologies?
Did Dynavax Technologies meet its revenue projections?
Dynavax Technologies financial information
| CEO | Ryan Spencer |
| Company Type | Public |
| Employees Number | 311 |
| Date Founded | 1996 |
| Headquarters | Berkeley, California |
| Number of Locations | 3 |
| Revenue | $277.2M |
| Net Income | $293,156,000 |
| Gross Proft | $227.8M (2024) |
| PE Ratio | 50.90 |
| Tax Rate | 0.1% |
| Market Capitalization | $1.4B |
| Total Assets | $985,850,000 |
| Ticker | DVAX |
Dynavax Technologies jobs you might like
Dynavax Technologies financing
Dynavax Technologies received early financing of $34.8M on 2002-04-25.
| Series | Round size | Date |
|---|---|---|
| Series D | $34.8M | 04/2002 |
| Post Ipo Equity | $29.4M | 10/2005 |
| Post Ipo Equity | $29.5M | 10/2006 |
| Post Ipo Debt | $30M | 07/2007 |
| Post Ipo Equity | $42M | 10/2010 |
| Grant | $600K | 09/2011 |
| Post Ipo Equity | $64.5M | 11/2011 |
| Debt Financing | $40M | 12/2014 |
| Post Ipo Equity | $135M | 07/2015 |
| Post Ipo Equity | $80.8M | 08/2017 |
| Post Ipo Debt | $175M | 02/2018 |
| Post Ipo Equity | $80.5M | 05/2020 |
| Grant | $3.4M | 08/2020 |
| Post Ipo Debt | $99M | 02/2021 |
| Post Ipo Debt | $200M | 05/2021 |
Dynavax Technologies investors
| Investors | Security type |
|---|---|
| BA Ventures | Series D |
| Axiom Venture Partners | Series D |
| Bain Capital Life Sciences | Series D |
| HealthCap | Series D |
| InterWest Partners | Series D |
| Alta Partners | Series D |
| Finedix BV | Series D |
| JAFCO Asia | Series D |
| PIPER SANDLER COMPANIES | Series D |
| Sanderling Ventures | Series D |
| BioVeda Capital | Series D |
| Forward Ventures | Series D |
| WestLB Asset Management | Series D |
| Lotus BioScience Ventures | Series D |
| Care Capital LLC | Series D |
| Deerfield Management | Post Ipo Debt |
| National Institute of Allergy and Infectious Diseases (NIAID) | Grant |
| HERCULES CAPITAL INC | Debt Financing |
| CRG LP | Post Ipo Debt |
| Bill & Melinda Gates Foundation | Grant |
| Coalition for Epidemic Preparedness Innovations | Post Ipo Debt |
Dynavax Technologies competitors
Dynavax Technologies's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.
Dynavax Technologies's smallest competitor is Morphotek with revenue of $4.8M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Geron | $56,851 | $77.0M | 15 | - |
| Idera Pharmaceuticals | $56,901 | $4.9M | 36 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 699 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Morphotek | $51,282 | $4.8M | 1 | - |
| FibroGen | $82,290 | $29.6M | 461 | - |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Peregrine Pharmaceuticals | $61,658 | $57.6M | 321 | - |
| MacroGenics | $77,691 | $150.0M | 307 | 11 |
| Nanogen | $54,140 | $8.5M | 10 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Dynavax Technologies highest paying jobs
Zippia gives an in-depth look into the details of Dynavax Technologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dynavax Technologies. The employee data is based on information from people who have self-reported their past or current employments at Dynavax Technologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dynavax Technologies. The data presented on this page does not represent the view of Dynavax Technologies and its employees or that of Zippia.
Dynavax Technologies may also be known as or be related to DYNAVAX TECHNOLOGIES CORP, Dynavax Technologies, Dynavax Technologies Corp, Dynavax Technologies Corp. and Dynavax Technologies Corporation.